Trump Requests Supreme Court to Intervene on TikTok Ban Andaman Offshore Exploration Reveals Hydrocarbon Potential Gas Find with 87 Methane International Aid Sector Faces Breaking Point as Legacy Models Struggle Under Funding Pressures Australian Taxpayers Subsidise Big Minings Fossil Fuel Use by 4bn Annually A Climate Contradiction Q4 Earnings Roundup EID Parry Reports Loss Marksans Pharma and Astra Microwave See Profit Gains AIA Engineering Declines IRCTC Shares Dip 3 as Q4 Marks First Profit Decline in Ten Quarters Dividend Declared NAMS Q1 2026 Earnings Narrowed Loss Per Share Surpasses Expectations Amid Continued Pipeline Development RZC Q1 2026 Earnings Strong EPS Beat of 1417 Surprises Analysts RadNet Inc RDNT Q1 2026 Earnings WiderThanExpected Loss Weighs on Shares Catalyst Pharmaceuticals CPRX Q1 2026 Earnings EPS Beat Signals Operational Strength Amid Quiet Revenue Reporting Coeur Mining CDE Q1 2026 Earnings EPS Misses Street Estimates as Costs Pressure Bottom Line Maiden Holdings MHLA Q3 2024 Earnings Net Loss Persists Despite Flat Revenue Environment Note Price Edges Higher EHang Holdings Dips 286 as Shares Approach Critical Support Zone Massimo Group MAMO Tests Key Support at 095 After Marginal Decline Knife Riv Holding Co KNF Surges 34 on Strong Volume Approaches Key Resistance enCore Energy Corp EU Edges Higher Amid Modest Uranium Sector Recovery WEC Energy Group WEC Holds Steady Near Support as Utility Sector Gains Momentum Piedmont Realty Trust PDM Holds Near Support After Modest Gain Crescent Energy CRGY Drops 455 Key Support Level in the Crosshairs LM Funding America LMFA Hovers Near Support as Minimal Decline Persists Carlyle Credit Income Fund Series D Preferred Shares CCID Hold Steady at 2535 Clorox CLX Gains Ground Consumer Staples Stock Rebounds Amid Defensive Demand Noble Corporation Edges Lower Amid Consolidation Phase NE Salesforce Beats Q4 Earnings and Revenue Estimates but FullYear Guidance Comes in Light STRRP Q1 2026 Earnings Preferred Stock Reports Sharp EPS Miss Yet Shares Gain Tempest Therapeutics TPST Edges Higher as Biotech Sector Shows Renewed Interest